To monitor dabigatran or not: a matter of patient safety

Clin Chem. 2015 May;61(5):691-3. doi: 10.1373/clinchem.2014.232207. Epub 2015 Feb 4.

Authors

Hemamalini Ketha¹, John R Mills²

Affiliations

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. [email protected].

PMID: 25652535
DOI: 10.1373/clinchem.2014.232207

No abstract available

MeSH terms

Antithrombins / analysis*
Benzimidazoles / analysis*
Dabigatran
Drug Monitoring*
Humans
Patient Safety*
beta-Alanine / analogs & derivatives*
beta-Alanine / analysis

Substances

Antithrombins
Benzimidazoles
beta-Alanine
Dabigatran